Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

Journal:

The New England Journal of Medicine

Published:

2025-06-03

DOI:

10.1056/nejmoa2415566

Affiliations:

15

Authors:

14

Go to article

Institutions	Authors	Share
Bayer, Germany	4.500000	0.32
Bayer Consumer Care AG, Switzerland	2.000000	0.14
Bayer Oy, Finland	1.000000	0.07
Bayer Plc, United Kingdom (UK)	1.000000	0.07
Liverpool Women's Hospital, United Kingdom (UK)	1.000000	0.07
Femicare, Belgium	0.500000	0.04
Charité - University Medicine Berlin, Germany	0.500000	0.04
Champalimaud Clinical Centre (CCC), Portugal	0.500000	0.04
Algarve Biomedical Center (ABC), Portugal	0.500000	0.04
Antwerp University Hospital (UZA), UA, Belgium	0.500000	0.04
Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, United Kingdom (UK)	0.500000	0.04
Imperial College London (ICL), United Kingdom (UK)	0.500000	0.04
University College Dublin (UCD), Ireland	0.500000	0.04
Mater Misericordae University Hospital (MMUH), Ireland	0.500000	0.04

Interested in Reproductive Medicine?